Dr. Anna I. Koulova, MD

Dr. Koulova practices at Stamford Health Medical Group, Inc. in Stamford, Connecticut.

Dr. Koulova's NPI, 1174967145, was assigned on April 22, 2013. Dr. Koulova graduated from New York Medical College in 2013. Dr. Koulova holds Connecticut license 62537.

Dr. Koulova's primary practice is Stamford Health Medical Group, Inc., at 1 Omega Dr, Stamford, CT 06907 in Western Ct County. The practice phone is (203) 276-7447.

Dr. Koulova's primary practice is Stamford Health Medical Group, Inc. in Stamford, Connecticut. Dr. Koulova is also affiliated with Stamford Hospital. The medical group on file is Stamford Health Medical Group. Dmand AI also links Dr. Koulova to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koulova practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Koulova's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Koulova is licensed in Connecticut.

CMS data shows 2,282 Medicare services from Dr. Koulova across 20 procedure codes in 2024, for 1,358 Medicare patients. Medicare paid $89,267 for them.

CMS counts 1,358 Medicare patients who saw Dr. Koulova in 2024. The largest group is 75 to 84, with 541 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koulova's median patient age at 62, with 56% women.

In 2024, Dr. Koulova wrote 1,307 Medicare Part D claims for 222 patients. 85% of them were for generic drugs. CMS names the drug for 1,216 of them, across 27 drugs with 11 or more claims each, at $249,349 in total drug cost. In 2023, CMS named 1,189 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Koulova for performance year 2024, reported as part of a group. Dr. Koulova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koulova as offering telehealth.

Dmand AI links 12 papers to Dr. Koulova, published from 2011 to 2025. 2012 was the busiest year, with 2. The most frequent topics are Cardiomyopathy, Hypertrophic. Dr. Koulova's most frequent co-authors are David H. Hsi, MD, Mark V. Sherrid, MD and Chirag Pankajkumar Bavishi, MD, MPH.

CMS Open Payments shows 16 general payments to Dr. Koulova from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $230.

Dr. Koulova graduated from New York Medical College in 2013.